Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap14.2B
Enterprise Value14.37B
P/E Ratio-63.2
PEG Ratio4.19
Price/Sales Ratio32.41
Price/Book Ratio65.88
Enterprise/Revenue33.15
Enterprise/EBITDA-118.16

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.52
Operating Margin-0.27
AD

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.78

Income Statement

Revenue416.37M
Revenue/Share2.67
Gross Profit259.49M
EBITDA-103.28M
Net Income-217.85M
Diluted EPS-1.37

Balance Sheet

Total Cash164.08M
Total Cash/Share1.03
Total Debt476.52M
Total Debt/Equity2.28
Current Ratio0.86
Book Value Per Share1.71

Price History

52-Week Change-27.85
52-Week High149
52-Week Low79
Moving Average 50 Days93.64
Moving Average 200 Days102.39

Statistics

Average Volume7.2M
Shares Outstanding159.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split Factor2:1
Last Split DateSeptember 16, 2015
AD